Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1b191dcdff1b949e72501c1ace7178e5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_64d16e1f53891f13d58676f49f21edcf http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7fe256f2e07b1769466465082fbd31ac |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2267-0356 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2227-105 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2217-072 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2217-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2217-075 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2267-03 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2267-0393 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-8509 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K67-0276 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-705 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-705 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-85 |
filingDate |
2002-03-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_79bd73061245b8e3868854bcda0ecc35 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f97f3683a80c123c543932bbf18323ed |
publicationDate |
2002-10-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-02079380-A2 |
titleOfInvention |
Disruptions in gaba receptor rh02 subunit, methods adn uses thereof |
abstract |
The present invention relates to compositions and methods relating to the characterization and function of GABRR2. Specifically, the present invention provides transgenic animals and methods of treating disease states or conditions in which the GABRR2 is implicated. The present invention also provides agents and method of identifying agents that modulate GABRR2. Such agents may be useful in treating and preventing conditions associated with pain. |
priorityDate |
2001-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |